Trinity Biotech plc (TRIB) Releases Q2 2025 Earnings: Revenue Decline and Wider Net Loss

By: Quiver EarningsTracker

Posted: 3 months, 1 week ago / Dec. 23, 2025 12:47 p.m. UTC

TRIB

Trinity Biotech plc (TRIB) — Q2 2025 results

Total revenue was $9.2 million, down 41.9% year-over-year.

Gross profit fell to $3.26 million, a decline of 43.1% year-over-year, with cost of sales at $5.94 million (down 41.2% YoY).

Operating loss narrowed to -$5.02 million, a 23.8% improvement versus the prior year.

Net loss attributable to common shareholders widened to -$14.76 million, up 118.5% year-over-year.

Diluted loss per share was -$0.16, representing a year-over-year change of -99.78%. The steep revenue and gross-profit declines indicate margin pressure, which contributed to the larger net loss despite the smaller operating loss.

Cash flow and balance sheet

Cash used in operating activities improved to -$2.30 million, up 108.5% year-over-year.

Capital expenditures were reduced to -$46,500, down 35.4% year-over-year.

Cash and cash equivalents stood at $1.55 million, down 70.9% year-over-year.

Total liabilities increased to $149.2 million, up 20.5% year-over-year.

Overall, Trinity Biotech plc (TRIB) reported a marked revenue contraction and compressed gross margins in Q2 2025, with improving operating cash flow but materially reduced cash balances and higher liabilities, which may constrain near-term financial flexibility.

Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

Trinity Biotech plc Hedge Fund Activity

We have seen 14 institutional investors add shares of Trinity Biotech plc stock to their portfolio, and 10 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

PERCEPTIVE ADVISORS LLC added 1,432,000 shares (+400.0%) to their portfolio in Q3 2025, for an estimated $1,489,280
RENAISSANCE TECHNOLOGIES LLC added 114,397 shares (+200.8%) to their portfolio in Q3 2025, for an estimated $118,972
HRT FINANCIAL LP removed 66,242 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $43,057
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC added 49,200 shares (+11.2%) to their portfolio in Q3 2025, for an estimated $51,168
CITADEL ADVISORS LLC added 39,384 shares (+inf%) to their portfolio in Q3 2025, for an estimated $40,959
CAPTRUST FINANCIAL ADVISORS added 27,247 shares (+inf%) to their portfolio in Q3 2025, for an estimated $28,336
XTX TOPCO LTD removed 25,751 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $26,781

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.